Resources

All resources

Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.

Filter by

December 05, 2022

The Suspension and reformulation of the PMPRB guidelines is urgently required: IMC response to PMPRB 2022 guidelines proposals

Innovative Medicines Canada has submitted formal feedback to the Patented Medicine Prices Review Board’s (PMPRB) revised Draft Guidelines public consultation, calling for a suspension of the planned implementation to ensure meaningful stakeholder consultation and a thorough impact analysis.

Learn more | View

Patented Medicine Prices Review Board (PMPRB)
1 2 3

resources

Discover. Learn.
Understand.

Stay informed with timely, relevant content on key issues shaping our industry.

Learn more